# Preoperative Intraarticular Injection of Methylprednisolone in Patients Scheduled for Total Knee-arthroplasty

> **NCT02253966** · PHASE2 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 48 (actual)

## Conditions studied

- Knee Joint Osteoarthrosis
- Hyperalgesia
- Severe Movement Related Pain

## Interventions

- **DRUG:** Methylprednisoloneacetate
- **DRUG:** Lidocaine
- **OTHER:** sodium chloride

## Key facts

- **NCT ID:** NCT02253966
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2016-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02253966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02253966, "Preoperative Intraarticular Injection of Methylprednisolone in Patients Scheduled for Total Knee-arthroplasty". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02253966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*